Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Noëlle Dufour"'
Autor:
Mathilde Louçã, Donya El Akrouti, Aude Lemesle, Morgane Louessard, Noëlle Dufour, Chloé Baroin, Aurore de la Fouchardière, Laurent Cotter, Hélène Jean-Jacques, Virginie Redeker, Anselme L. Perrier
Publikováno v:
Neurobiology of Disease, Vol 202, Iss , Pp 106703- (2024)
Externí odkaz:
https://doaj.org/article/9b7b2a86457a4b27aeb7d79b1e947592
Autor:
Mathilde Louçã, Donya El Akrouti, Aude Lemesle, Morgane Louessard, Noëlle Dufour, Chloé Baroin, Aurore de la Fouchardière, Laurent Cotter, Hélène Jean-Jacques, Virginie Redeker, Anselme L. Perrier
Publikováno v:
Neurobiology of Disease, Vol 200, Iss , Pp 106630- (2024)
Despite growing descriptions of wild-type Huntingtin (wt-HTT) roles in both adult brain function and, more recently, development, several clinical trials are exploring HTT-lowering approaches that target both wt-HTT and the mutant isoform (mut-HTT) r
Externí odkaz:
https://doaj.org/article/014f66c687ef4b789460f73ea00cc84e
Autor:
Noémie Cresto, Marie-Claude Gaillard, Camille Gardier, Francesco Gubinelli, Elsa Diguet, Déborah Bellet, Laurine Legroux, Julien Mitja, Gwenaëlle Auregan, Martine Guillermier, Charlène Josephine, Caroline Jan, Noëlle Dufour, Alain Joliot, Philippe Hantraye, Gilles Bonvento, Nicole Déglon, Alexis-Pierre Bemelmans, Karine Cambon, Géraldine Liot, Emmanuel Brouillet
Publikováno v:
Neurobiology of Disease, Vol 134, Iss , Pp - (2020)
The G2019S substitution in the kinase domain of LRRK2 (LRRK2G2019S) is the most prevalent mutation associated with Parkinson's disease (PD). Neurotoxic effects of LRRK2G2019S are thought to result from an increase in its kinase activity as compared t
Externí odkaz:
https://doaj.org/article/f99d8776c12c4a7bb6880f866319890e
Autor:
Valérie Drouet, Marta Ruiz, Diana Zala, Maxime Feyeux, Gwennaëlle Auregan, Karine Cambon, Laetitia Troquier, Johann Carpentier, Sophie Aubert, Nicolas Merienne, Fany Bourgois-Rocha, Raymonde Hassig, Maria Rey, Noëlle Dufour, Frédéric Saudou, Anselme L Perrier, Philippe Hantraye, Nicole Déglon
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e99341 (2014)
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder resulting from polyglutamine expansion in the huntingtin (HTT) protein and for which there is no cure. Although suppression of both wild type and mutant HTT expression by R
Externí odkaz:
https://doaj.org/article/53fb4717c2244083b8f7184a75b42623
Autor:
Elsa Diguet, Fanny Petit, Carole Escartin, Karine Cambon, Nicolas Bizat, Noëlle Dufour, Philippe Hantraye, Nicole Déglon, Emmanuel Brouillet
Publikováno v:
PLoS ONE, Vol 4, Iss 2, p e4637 (2009)
Aging likely plays a role in neurodegenerative disorders. In Huntington's disease (HD), a disorder caused by an abnormal expansion of a polyglutamine tract in the protein huntingtin (Htt), the role of aging is unclear. For a given tract length, the p
Externí odkaz:
https://doaj.org/article/05c5333cf7b94ae0824b4acd577e12e4
Autor:
Sandro Alves, Isabel Nascimento-Ferreira, Gwennaëlle Auregan, Raymonde Hassig, Noëlle Dufour, Emmanuel Brouillet, Maria C Pedroso de Lima, Philippe Hantraye, Luís Pereira de Almeida, Nicole Déglon
Publikováno v:
PLoS ONE, Vol 3, Iss 10, p e3341 (2008)
Recent studies have demonstrated that RNAi is a promising approach for treating autosomal dominant disorders. However, discrimination between wild-type and mutant transcripts is essential, to preserve wild-type expression and function. A single nucle
Externí odkaz:
https://doaj.org/article/2766a5d9287248fead8a3c51410d315a
Autor:
Laurene Abjean, Lucile Ben Haim, Miriam Riquelme-Perez, Pauline Gipchtein, Céline Derbois, Marie-Ange Palomares, Fanny Petit, Anne-Sophie Hérard, Marie-Claude Gaillard, Martine Guillermier, Mylène Gaudin-Guérif, Gwenaelle Aurégan, Nisrine Sagar, Cameron Héry, Noëlle Dufour, Noémie Robil, Mehdi Kabani, Ronald Melki, Pierre De la Grange, Alexis P. Bemelmans, Gilles Bonvento, Jean-François Deleuze, Philippe Hantraye, Julien Flament, Eric Bonnet, Solène Brohard, Robert Olaso, Emmanuel Brouillet, Maria-Angeles Carrillo-de Sauvage, Carole Escartin
Publikováno v:
Brain-A Journal of Neurology
Brain-A Journal of Neurology, 2022, ⟨10.1093/brain/awac068/6550082⟩
Brain-A Journal of Neurology, 2022, ⟨10.1093/brain/awac068/6550082⟩
Huntington’s disease is a fatal neurodegenerative disease characterized by striatal neurodegeneration, aggregation of mutant Huntingtin and the presence of reactive astrocytes. Astrocytes are important partners for neurons and engage in a specific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f88d3abc1e6f550b8912f6292213de5
https://doi.org/10.1101/2021.04.29.441924
https://doi.org/10.1101/2021.04.29.441924
Autor:
Francesco Gubinelli, Noémie Cresto, Marie-Claude Gaillard, Gwenaëlle Auregan, Martine Guillermier, Camille Gardier, Charlène Josephine, Fanny Petit, Caroline Jan, Pauline Gipchtein, Noëlle Dufour, Philippe Hantraye, Géraldine Liot, Alexis Pierre Bemelmans, Emmanuel Brouillet
Alpha-synuclein (α-syn) and leucine-rich repeat kinase 2 (LRRK2) are two proteins that play crucial roles in both sporadic and familial forms of Parkinson’s disease (PD). Recent data suggest the existence of an interplay between these two proteins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bed3e87aad0e264aa8d447cf2b9a9c6
Autor:
C. Gerard, Marie-Noëlle Dufour, R. Rasolonjanahary, Alain Enjalbert, Gilles Guillon, Vincent Homburger
Publikováno v:
Endocrinology. 143:747-754
Dopamine (DA) is known to inhibit basal and hormone TRH- or angiotensin II (AngII)-stimulated PRL secretion and inositol phosphate accumulation in rat pituitary cells in primary culture. This inhibition persists when cells are incubated in a calcium-
Publikováno v:
Endocrinology. 138:3299-3307
In 3-day primary cultures of rat glomerulosa cells, a 30-min preincubation with either 10 μm colchicine (a microtubule-disrupting agent) or 10 μm cytochalasin B (a microfilament-disrupting agent) decreased angiotensin II (Ang II)-induced inositol p